And the mazdutide comparison examines another dual agonist being developed in China
[DOI] [PMC free article] [PubMed] [Google Scholar] 32.Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR
Research published in Nature in April 2026 identified a variant in the GLP1R gene associated with reduced efficacy across GLP-1 medications
Antioxidant Potential (1) (2) (1) Antioxidant Potential Palmitoyl Tripeptide-1: Antioxidant Potential Palmitoyl Tripeptide-1, also known as Pal-GHK or Palmitoyl oligopeptide, is a peptide hypothesized to have significant potential as both an effective antioxidant and a skin-modulating agent
For aesthetic medicine practitioners, understanding the nuances of this new treatment optionincluding its efficacy, dosing requirements, and costis key to guiding patients holistically through their aesthetic and wellness journeys